CATALENT, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55 USD | -0.67% |
|
-1.43% | +22.41% |
| 05-16 | Argus Downgrades Catalent to Sell From Buy | MT |
| 05-14 | Novo Nordisk Selling $5 Billion in Bonds to Back Catalent Deal | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 10.02B | - | |||||
| 693B | ||||||
| 584B | ||||||
| 372B | ||||||
| 332B | ||||||
| 294B |
- Stock Market
- Equities
- CTLT Stock
- Charts Catalent, Inc.
- Sector Chart
